Black Diamond Therapeutics Inc. (BDTX) – Don’t Be So Quick to Call it Dead

Black Diamond Therapeutics Inc. (NASDAQ: BDTX) is 0.79% higher on its value in year-to-date trading and has touched a low of $17.63 and a high of $46.25 in the current 52-week trading range. The BDTX stock was last observed hovering at around $41.97 in the last trading session, with the day’s loss setting it -2.18%.

The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


Currently trading at $39.79, the stock is 0.70% and 1.40% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 86098.0 and changing -5.19% at the moment leaves the stock 16.72% off its SMA200. The firm has a 50-day simple moving average (SMA 50) of $39.98 and a 200-day simple moving average (SMA200) of $34.09.

The stock witnessed a 1.90% gain in the last 1 month and extending the period to 3 months gives it a 56.65%, and is -11.18% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.08% over the week and 9.73% over the month.

Distance from 52-week low is 125.69% and -13.97% from its 52-week high.

Black Diamond Therapeutics Inc. (BDTX) Analyst Forecasts

Black Diamond Therapeutics Inc. is expected to release its quarterly report on 09/02/2020 and quarterly earnings per share for the current quarter are estimated at -$0.44.The EPS is expected to shrink by -294.80% this year.

Black Diamond Therapeutics Inc. (BDTX) Top Institutional Holders

51 institutions hold shares in Black Diamond Therapeutics Inc. (BDTX), with 1.4M shares held by insiders accounting for 3.91% while institutional investors hold 74.58% of the company’s shares. The shares outstanding are 23.70M, and float is at 15.84M with Short Float at 17.84%. Institutions hold 71.67% of the Float.

The top institutional shareholder in the company is NEA Management Company, LLC with over 3.45 million shares valued at $86.07 million. The investor’s holdings represent 9.61% of the BDTX Shares outstanding. As of Mar 30, 2020, the second largest holder is RA Capital Management, L.P. with 2.59 million shares valued at $64.62 million to account for 7.21% of the shares outstanding. The other top investors are Boxer Capital, LLC which holds 2.01 million shares representing 5.61% and valued at over $50.27 million, while Artal Group S.A. holds 4.72% of the shares totaling 1.7 million with a market value of $42.33 million.

Black Diamond Therapeutics Inc. (BDTX) Insider Activity

A total of 5 insider transactions have happened at Black Diamond Therapeutics Inc. (BDTX) in the last six months, with sales accounting for 0 and purchases happening 5 times.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free